In these consensus guidelines the International Myeloma Society have reviewed existing literature and current guidelines to address issues associated with the risk of infection and prevention of infectious complications in multiple myeloma in the context of emerging therapies, and offer recommendations for preventing these complications.
Read the guidelines and recommendations here.